KIAA1549 is a gene located on chromosome 7 with emerging roles in both neural development and photoreceptor function. According to UniProt annotations, it may play a role in photoreceptor function and localizes to the photoreceptor connecting cilium and plasma membrane, suggesting involvement in sensory cell maintenance 1. However, KIAA1549's primary clinical significance derives from its involvement in pediatric brain tumors. The gene is most notable as a fusion partner with BRAF in pilocytic astrocytomas, the most common pediatric brain tumor 2. The KIAA1549-BRAF fusion is the most frequently identified genetic alteration in these tumors, occurring in approximately 45% of low-grade pediatric astrocytoma cases 3. This fusion aberration activates the RAS/MAPK signaling pathway, driving tumor growth 4. The KIAA1549-BRAF fusion has become clinically important for treatment stratification: patients with this fusion are responsive to MEK inhibitors like selumetinib and type II RAF inhibitors like tovorafenib, which have demonstrated improved outcomes compared to standard chemotherapy 5, 6. Additionally, KIAA1549 mutations have been identified as candidate disease genes in retinal dystrophy, supporting its role in photoreceptor biology 1.